Literature DB >> 23315608

Right ventricular function and survival following cardiac resynchronisation therapy.

Darryl P Leong1, Ulas Höke, Victoria Delgado, Dominique Auger, Tomasz Witkowski, Joep Thijssen, Lieselot van Erven, Jeroen J Bax, Martin J Schalij, Nina Ajmone Marsan.   

Abstract

OBJECTIVES: Right ventricular (RV) function is an important prognostic marker in heart failure. However, its impact on all-cause mortality following cardiac resynchronisation therapy (CRT) independent of confounding factors has not been evaluated. Furthermore, evidence concerning the effect of CRT on RV function is limited. The study's aims were to: (1) assess the prognostic importance of RV function among CRT recipients, and (2) characterise RV functional change following CRT and its determinants.
DESIGN: Retrospective observational study.
SETTING: Single tertiary centre. PATIENTS: A total of 848 CRT recipients (median age 65 years, 78% male, 60% ischaemic) underwent echocardiography before and 6 months after CRT. RV function was evaluated using tricuspid annular plane systolic excursion (TAPSE), with a ≤14 mm threshold indicating severe RV impairment. The primary endpoint was long-term all-cause mortality.
RESULTS: Significant baseline RV dysfunction was observed in 286 (34%) individuals. After a median 44 months, 288 deaths occurred. RV impairment was associated with a greater incidence of all-cause mortality (log-rank p<0.001). Independent predictors of this endpoint were functional class, ischaemic aetiology, diabetes, atrial fibrillation, renal dysfunction, bigger left ventricular (LV) end-systolic volume, less LV dyssynchrony and reduced TAPSE. Importantly, TAPSE added prognostic value to these recognised prognostic parameters (likelihood-ratio test p<0.001). Furthermore, improvement in RV function after CRT was independent of the improvement in LV systolic function but significantly associated with the improvement in LV diastolic function. Importantly, a favourable RV functional response to CRT was associated with superior survival.
CONCLUSIONS: RV function is an independent predictor of long-term outcome following CRT.

Entities:  

Mesh:

Year:  2013        PMID: 23315608     DOI: 10.1136/heartjnl-2012-303076

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  11 in total

1.  Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels.

Authors:  Cinzia Valzania; Mauro Biffi; Rachele Bonfiglioli; Francesco Fallani; Cristian Martignani; Igor Diemberger; Matteo Ziacchi; Jessica Frisoni; Luciana Tomasi; Stefano Fanti; Claudio Rapezzi; Giuseppe Boriani
Journal:  J Nucl Cardiol       Date:  2017-06-30       Impact factor: 5.952

2.  Cardiac resynchronization therapy in chronic heart failure: Effect on right ventricular function.

Authors:  Dominik C Benz; Aju P Pazhenkottil
Journal:  J Nucl Cardiol       Date:  2017-06-28       Impact factor: 5.952

Review 3.  Changes in parameters of right ventricular function with cardiac resynchronization therapy.

Authors:  Abhishek Sharma; Carl J Lavie; Ajay Vallakati; Akash Garg; Sunny Goel; Jason Lazar; Gregg C Fonarow
Journal:  Clin Cardiol       Date:  2017-09-12       Impact factor: 2.882

4.  Semi-automated echocardiographic quantification of right ventricular size and function.

Authors:  Diego Medvedofsky; Karima Addetia; Jamie Hamilton; Javier Leon Jimenez; Roberto M Lang; Victor Mor-Avi
Journal:  Int J Cardiovasc Imaging       Date:  2015-05-07       Impact factor: 2.357

5.  QRS duration versus morphology and survival after cardiac resynchronization therapy.

Authors:  Mand J H Khidir; Victoria Delgado; Nina Ajmone Marsan; Martin J Schalij; Jeroen J Bax
Journal:  ESC Heart Fail       Date:  2016-12-01

6.  Prognostic value of the MELD-XI score in patients undergoing cardiac resynchronization therapy.

Authors:  Yuki Saito; Toshiko Nakai; Yukitoshi Ikeya; Rikitake Kogawa; Naoto Otsuka; Yuji Wakamatsu; Sayaka Kurokawa; Kimie Ohkubo; Koichi Nagashima; Yasuo Okumura
Journal:  ESC Heart Fail       Date:  2022-01-04

7.  Development and Validation of Predictive Models of Cardiac Mortality and Transplantation in Resynchronization Therapy.

Authors:  Eduardo Arrais Rocha; Francisca Tatiana Moreira Pereira; José Sebastião Abreu; José Wellington O Lima; Marcelo de Paula Martins Monteiro; Almino Cavalcante Rocha Neto; Camilla Viana Arrais Goés; Ana Gardênia P Farias; Carlos Roberto Martins Rodrigues Sobrinho; Ana Rosa Pinto Quidute; Maurício Ibrahim Scanavacca
Journal:  Arq Bras Cardiol       Date:  2015-08-07       Impact factor: 2.000

8.  Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients.

Authors:  Vivien Klaudia Nagy; Gábor Széplaki; Astrid Apor; Valentina Kutyifa; Attila Kovács; Annamária Kosztin; Dávid Becker; András Mihály Boros; László Gellér; Béla Merkely
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

9.  Combination of Left Ventricular End-Diastolic Diameter and QRS Duration Strongly Predicts Good Response to and Prognosis of Cardiac Resynchronization Therapy.

Authors:  Zhinian Guo; Xiaoyan Liu; Xiaofeng Cheng; Chuan Liu; Ping Li; Yongming He; Rongsheng Rao; Chun Li; Yunlong Chen; Yong Zhang; Xiaoyu Luo; Jiang Wang
Journal:  Cardiol Res Pract       Date:  2020-01-17       Impact factor: 1.866

10.  Prognostic value of galectin-3 and right ventricular function for long-term mortality in heart failure patients treated with cardiac resynchronization therapy.

Authors:  Beata Zaborska; Ewa Pilichowska-Paszkiet; Ewa Makowska; Grażyna Sygitowicz; Tomasz Słomski; Michał Zaborski; Andrzej Budaj
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.